Safety of Dabigatran Etexilate in Blood Clot Prevention in Children

Clinical trial NCT02197416 · COMPLETED

Trial details

NCT number: NCT02197416
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Venous Thromboembolism Secondary Prevention

Start date: 2014-09-29
Primary completion: 2019-10-16
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.